Stock comparison
Merck & Co., Inc. is 175.2x more valuable than HUTCHMED (China) Ltd by market capitalization ($364.37 B vs $2.08 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Merck & Co., Inc. is 175.2x more valuable than HUTCHMED (China) Ltd by market capitalization ($364.37 B vs $2.08 B).
Market value leader
MRK
Merck & Co., Inc. is 175.2x more valuable than HUTCHMED (China) Ltd by market capitalization ($364.37 B vs $2.08 B).
Revenue leader
MRK
HCM: $548.51M vs MRK: $65.01B.
Profit leader
MRK
HCM: $456.91M vs MRK: $18.25B.
Margin leader
HCM
HCM: 83.3% vs MRK: 28.1% net margin.
| Metric | HCM | MRK |
|---|---|---|
| Market cap | $2.08 B | $364.37 B |
| US-listed rank | #2110 | #35 |
| Revenue (latest FY) | $548.51M | $65.01B |
| Net income (latest FY) | $456.91M | $18.25B |
| Net margin | 83.3% | 28.1% |
| P/E (trailing FY) | 4.6x | 20.0x |
| SEC filings | 589 | 998 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Merck & Co., Inc. is 175.2x more valuable than HUTCHMED (China) Ltd by market capitalization ($364.37 B vs $2.08 B).
In their latest fiscal years, HUTCHMED (China) Ltd reported $548.51M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: HUTCHMED (China) Ltd and Merck & Co., Inc., or browse the full rankings.